Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day ...

Adam Meeks expands on his short film of the same name in this debut feature integrating professional actors with ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Murrill wants the agency to reverse regulatory action it took in 2023 in response to the COVID-19 pandemic, when patient ...

DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...

Unicycive Therapeutics (UNCY) stock gains as the resubmitted marketing application for the kidney disease drug undergoes FDA review. Read more here.

The Center for Devices and Radiological Health said it is on track to meet review times specified by user fee agreements, ...

A cohort study of liver transplant candidates with HCC suggested that local-regional therapy with yttrium-90 transarterial ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.

HHS has rescinded a civil rights guidance directed at the nation’s retail pharmacies, reversing a directive that outlined their legal obligations to dispense medications tied to reproductive health.

The Department of Transportation’s operating agencies have announced their random drug and alcohol testing rates for 2026. The rates are the same as 2025, except that the FRA Mechanical annual random ...

A "grossly incompetent or grossly negligent" Manitoba nurse has been stripped of her licence and fined $10,000 after ...